This is a translation of the Swedish press release published 2023-04-26
Approved grant from Vinnova for a collaborative project together with Lund University and Skåne University Hospital, attendance at Pediatric Academic Societies meeting 2023, the market preparations that has been initiated before launch through a collaboration with 99NICU and visits to neonatal intensive care units in Germany and Gothenburg – CEO tells more in Neola Medical’s investor letter for April 2023.
In the spring investor letter CEO Hanna Sjöström tells more about the grant that Neola Medical together with Lund University and Skåne University Hospital has been granted for a collaborative project that will investigate the possibilities for lung monitoring of a new patient group. Also, attendance at Pediatric Academic Societies (PAS) meeting 2023 in Washington D.C. and publication of a White Paper about the technology in Neola® is highlighted in the investor letter. Moreover, Clinical Manager Tetiana Kovtiukh talks about the collaboration with 99NICU that initiate the market preparations before launch of Neola®, as well as her visits to neonatal intensive care units (NICUs).
Read the entire press release, including the investor letter, here (in Swedish): Press release